Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study
European Journal of Neurology · 2025-01 · 32 (1)
DOI: 10.1111/ene.70019 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Neurology, online erschienen am 25.12.2024. Verfasst von Viviana Nociti und 19 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Research Center 'Anna Paola Batocchi', Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuo…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Comorbidity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The study aims to examine the age and disability levels at diagnosis in people with multiple sclerosis (PwMS), with and without autoimmune comorbidities (AC), and the effect of AC on NEDA‐3 status and to characterize AC associated with MS, comparing also therapeutic approaches between MS patients with and without other AC.
Methods
This population‐based, multicentric study enrolled patients with relapsing–remitting MS (RRMS) with AC (AC group) or without AC (reference group) from 14 MS centers. Demographical, clinical features, treatment information, MRI activity, EDSS, and no evidence of disease activity (NEDA‐3) status were assessed at T36 (enrollment time) and T0 (36 months prior).
Results
Eight hundred seventy‐three RRMS patients were included; 215 (24.7%) presented with at least one AC. The AC group was characterized by higher proportion of female patients than reference group ( p = 0.008). Patients with AC, compared to reference group, exhibited older age at MS onset and MS diagnosis, and higher EDSS score at diagnosis, at T0 (all p < 0.001), and T36 ( p = 0.03). The proportion of patients reaching EDSS 4 was higher in reference group than AC group ( p = 0.03). People in AC group were more often treated with glatiramer acetate, natalizumab, and rituximab, whereas PwMS from reference group with interferon‐beta and fingolimod at T0 and T36. The risk of losing NEDA‐3 was lower in AC group (OR = 0.61, 95% CI 0.43–0.86, p = 0.005).
Conclusions
AC are common in PwMS and can be related to a delay in onset, diagnosis and higher disability at MS presentation. However, the coexistence of AC is not associated with a worse prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Multiple Sclerosis Research Center 'Anna Paola Batocchi', Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
- Multiple Sclerosis Center, Neurology Unit S. Camillo-Forlanini Hospital, Rome, Italy.
- Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milan, Italy.
- Department of Biomedicine, Neurosciences and advanced Diagnostics, University of Palermo, Palermo, Italy.
- Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Caserta, Italy.
- Neurological Clinic-Stroke Unit and Multiple Sclerosis Center, "A. Cardarelli" Hospital, Naples, Italy.
ORCID-Profile: Viviana Nociti, Marina Romozzi, Luca Prosperini, Paolo Ragonese, Antonio Gallo, Massimiliano Di Filippo, Lorena Lorefice, Diana Ferraro, Claudio Solaro, Claudio Gasperini
Zitieren
APA
Nociti, V., Romozzi, M., Prosperini, L., Clerici, V. T., Ragonese, P., Gallo, A., Maniscalco, G. T., Di Filippo, M., Buscarinu, M. C., Lorefice, L., Pinardi, F., Gajofatto, A., Cavalla, P., Buttari, F., Ferraro, D., De Luca, G., Solaro, C., Gasperini, C., Cocco, E., & RIREMS Study Group (2025). Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study. European Journal of Neurology, 32(1). https://doi.org/10.1111/ene.70019
Vancouver
Nociti V, Romozzi M, Prosperini L, Clerici VT, Ragonese P, Gallo A, et al. Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study. European Journal of Neurology. 2025;32(1). doi:10.1111/ene.70019
BibTeX
@article{Nociti2025,
author = {Nociti, Viviana and Romozzi, Marina and Prosperini, Luca and Clerici, Valentina Torri and Ragonese, Paolo and Gallo, Antonio and Maniscalco, Giorgia Teresa and Di Filippo, Massimiliano and Buscarinu, Maria Chiara and Lorefice, Lorena and Pinardi, Federica and Gajofatto, Alberto and Cavalla, Paola and Buttari, Fabio and Ferraro, Diana and De Luca, Giovanna and Solaro, Claudio and Gasperini, Claudio and Cocco, Eleonora and RIREMS Study Group, RIREMS Study Group},
title = {Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study},
journal = {European Journal of Neurology},
year = {2025},
volume = {32},
number = {1},
doi = {10.1111/ene.70019}
}
EUVIMED